As of . Rebuilt every trading night.
The most concentrated genomics ETFs
Two funds on one theme can hold ten names or two hundred. That is the choice this list is about, and it is not visible in either fund’s name.
| # | Ticker | Fund | Top ten weight | Holdings | Net assets | Total return, 1Y |
|---|---|---|---|---|---|---|
| 1 | ARKG | ARK Genomic Revolution ETF | 60.4% | 33 | $2.2bn | +87.1% |
| 2 | GNOM | Global X Genomics & Biotechnology ETF | 52.7% | 52 | $100m | +77.5% |
| 3 | IDNA | iShares Genomics Immunology and Healthca | 46.2% | 62 | $271m | +73.4% |
| 4 | GNMX | Corgi Genomics & Precision Medicine ETF | 45.1% | 58 | $3m | too new |
Method
The 4 of 4 ETFs in the genomics and gene editing theme with a filed book, most concentrated first. Across the funds listed here the weight in the ten largest runs from 45.1% to 60.4%. Concentration is not a fault. It is how much of the fund rides on ten decisions. The ranking is the published field sorted, nothing else: no scoring, no weighting and no view on any fund. Every fund ETFIQ covers in this category is eligible, including funds that have closed, because leaving them out would flatter the category.
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
A ranking is not a recommendation and no order on this site is an opinion. ETFIQ is an independent publisher, not an adviser. Standards and sources
Cite this page. ETFIQ, The most concentrated genomics ETFs, ranked by the share of the fund held in its ten largest positions, data as of Sep 18, 2026. https://etfiq.com/rankings/themes-concentrated-genomics Free to use with attribution; the underlying files are at Open data.